Onyx Pharmaceuticals Announces Fourth Quarter and Year-End 2004 Financial Results Webcast and Teleconference
EMERYVILLE, Calif — Feb. 25, 2005
Contact:
Julie Wood
510-597-6505
Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today announced that it will webcast a teleconference discussing its fourth quarter and year-end 2004 financial results on Thursday, March 3, 2005, at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time). Financial results for the fourth quarter and year ended December 31, 2004 will be released earlier that day.
Interested parties may access a live webcast of the presentation at:
http://phx.corporate-ir.net/playerlink.zhtml?c=112065&s=wm&e=1011241
or by dialing 617-614-3670 and using the passcode 37731924. A replay of the presentation will be available on the Onyx website or by dialing 617-801-6888 and using the passcode 70845601 approximately one hour after the teleconference concludes. The replay will be available through April 3, 2005.
Onyx Pharmaceuticals is engaged in the development of novel cancer therapies that target the molecular basis of cancer. With its collaborators, the company is developing small molecule drugs, including BAY 43-9006 with Bayer Pharmaceuticals Corporation. For more information about Onyx's pipeline and activities, visit the company's website at www.onyx-pharm.com.
Back to 2005 Press Releases
